Reata, Dycom rise; Novavax, Ambarella fall

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Wednesday:

Monster Beverage Corp., down $2.57 to $99.19.

The energy drink maker reported weak fourth-quarter results.

Ambarella Inc., down $10.84 to $83.47.

The video-compression chipmaker’s revenue forecast fell short of Wall Street expectations.

Novavax Inc., down $2.40 to $6.86.

The vaccine maker warned investors about its ability to remain in business.

Payoneer Global Inc., up 80 cents to $6.60.

The global payments company gave investors a strong revenue forecast.

Reata Pharmaceuticals Inc., up $62 to $93.17.

The biopharmaceutical company’s treatment for Friedreich’s ataxia, a rare disease, received U.S. regulatory approval.

Dycom Industries Inc., up $12.81 to $97.02.

The provider of specialty contracting services reported strong fourth-quarter financial results.

First Solar Inc., up $26.54 to $195.68.

The solar power systems company beat analysts’ fourth-quarter earnings forecasts.

Sarepta Therapeutics Inc., up $23.50 to $145.63.

The biopharmaceutical company’s fourth-quarter earnings and revenue beat analysts’ forecasts.

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up